five

Physiological Assessment of ECCO<sub>2</sub>R on the Work of Breathing in Exacerbations of COPD

收藏
DataCite Commons2024-12-06 更新2025-01-06 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Physiological_Assessment_of_ECCO_sub_2_sub_R_on_the_Work_of_Breathing_in_Exacerbations_of_COPD/27978849/1
下载链接
链接失效反馈
官方服务:
资源简介:
The impact of extracorporeal carbon dioxide removal (ECCO<sub>2</sub>R) on work of breathing and aeration in exacerbations of chronic obstructive pulmonary disease (AECOPD) is poorly understood. The study explores the impact of non-invasive ventilation (NIV) and ECCO<sub>2</sub>R on respiratory drive, effort and distribution of ventilation in AECOPD. Patients enrolled in a randomised controlled study of the addition of ECCO<sub>2</sub>R to NIV compared with NIV underwent oesophageal pressure measurement, electrical impedance tomography and parasternal electromyography. 18 patients were enrolled, nine in each arm. Of these, eight in the NIV arm and seven in the ECCO<sub>2</sub>R arm underwent physiological assessment. Patients randomised to ECCO<sub>2</sub>R, had a period of NIV combined with ECCO<sub>2</sub>R and, after removal of NIV, a period of ECCO<sub>2</sub>R alone. The removal of NIV whilst remaining on ECCO<sub>2</sub>R resulted in a respiratory acidosis (pH 7.34 (7.31–7.34) vs. 7.31 (7.31–7.34), <i>p</i> &lt; 0.0001), increased work of breathing (7.43 (6.08–10.19) vs. 11.1 (8.11–15.15) J/min, <i>p</i> &lt; 0.0001) and increased neural drive (884.4 (684.7–967.3) vs. 1321.1 (903.3–1575.3) AU, <i>p</i> = 0.0005). On day 1, the work of breathing was lower in the NIV than the ECCO<sub>2</sub>R group (4.38 (2.76–7.27) vs. 8.03 (4.8–15.94) J/min, <i>p</i> &lt; 0.0001), minute ventilation was higher (15.54 (13.14–18.48) vs. 12.24 (8.51–13.9) L/min, <i>p</i> &lt; 0.0001) and neural drive was the same (1,163.8 (1,085.5–1,325.5) vs. 1,093.8 (885.7–1,258.7) AU, <i>p</i> = 0.5556). The combination of NIV and ECCO<sub>2</sub>R results in lower work of breathing and improved neuro-ventilatory coupling. NIV fully supports ventilation early whilst ECCO<sub>2</sub>R improves neuro-ventilatory coupling and work of breathing over time. Clinicaltrials.gov; NCT02086084; registered 1 December 2015; https://clinicaltrials.gov/study/NCT02086084?cond=copd&amp;term=ecco2r&amp;rank=4
提供机构:
Taylor & Francis
创建时间:
2024-12-06
二维码
社区交流群
二维码
科研交流群
商业服务